Skip to content

Writing for adults with type 2 diabetes

Written emotional disclosure for adults with type 2 diabetes: a single centre parallel group randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN18442976
Enrollment
142
Registered
2009-11-11
Start date
2009-02-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes Nutritional, Metabolic, Endocrine Non-insulin-dependent diabetes mellitus

Interventions

Intervention: Written Emotional Disclosure. This involves writing about personal thoughts and feelings about a stressful event. Control: A neutral writing condition in which people describe how they u

Sponsors

University of Warwick (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years, either sex 2. Have been diagnosed with type 2 diabetes for more than 6 months 3. Have scored below a cut off for significant depressive symptoms in an eligibilty check (Centre for Epidemiological Studies Depression (CES-D) questionnaire less than 16)

Exclusion criteria

Exclusion criteria: 1. Have received a diagnosis of psychotic or bipolar disorder 2. Are currently receiving treatment for depression 3. Are currently receiving any psychological therapy for any reason 4. Have any history of self harm, suicidal ideation or suicide attempts 5. Have received a care provider assessment as unsuitable (e.g. if they are receiving end of life care, are acutely ill or have any past or present psychological vulnerabilities)

Design outcomes

Primary

MeasureTime frame
Symptoms of depression, measured by the CES-D at baseline and then 3 and 6 months post-intervention

Secondary

MeasureTime frame
Measured at baseline and 3 and 6 months post-intervention: 1. Diabetes specific emotional distress measured with the Problem Areas in Diabetes (PAID) Scale 2. Health care use measured with the Stanford Patient Education Research Centre Diabetes Health Care Utilisation Questionnaire 3. Diabetes self care behaviours measured with the Summary of Diabetes Self-care Activities Questionnaire (SDCAQ) 4. Glycaemic control (HbA1c) obtained from routine medical records 5. Health related quality of life measured with the EuroQoL

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026